Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Verastem, De Risked?
Article By:
Zion Miller
Monday, December 31, 2018 4:11 PM EDT
VSTM has been pushed down for several reasons and was further damaged with the recent unfortunate bearish markets.
In this article: VSTM
Week In Review: Agilent Pays $250 Million To Acquire ACEA And Its Cell Therapy Analyzer
Article By:
ChinaBio® Today
Saturday, September 29, 2018 4:11 PM EDT
ACEA Biosciences, a San Diego company with R&D and manufacturing facilities in Hangzhzou, will be acquired by Agilent for $250 million in cash. ACEA developed the xCELLigence® cell therapy analysis device used by academic and biopharma researchers.
VSTM Verastem Inc – Bullish Break
Article By:
Elliottwave Forecast
Wednesday, September 13, 2017 6:00 AM EDT
VSTM Verastem Inc has created a bullish break in the weekly time frame after the announcement of Positive Top-Line Data For Leukemia Treatment
In this article: VSTM